Latest Orphan drug Stories
A company that produces a cancer vaccine called CRS-207 has been granted orphan drug status for the treatment of malignant mesothelioma, potentially opening new treatment possibilities for patients
Indian Government to grant trial waiver for Orphan Drugs if certain criteria are met RESEARCH TRIANGLE PARK, N.C., March 31, 2015 /PRNewswire/ -- Dr.
LA JOLLA, Calif., March 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
CALGARY, March 25, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
The announcement that a new drug has been granted “orphan” status by the FDA could pave the way for an alternative mesothelioma therapy. Raleigh, NC (PRWEB)
CALGARY, March 3, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
CAMBRIDGE, Mass., Feb.
SALT LAKE CITY, Feb.
WASHINGTON, Feb. 24, 2015 /PRNewswire-USNewswire/ -- Over 200 patient advocates are in Washington D.C.
- A young chicken: also used as a pet name for children.